V. Vicente

V. Vicente, J. Rivera, L. Larrea, 2009, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma‐bearing C57BL6 mice

M. A. Rol, V. Vicente, J. A. Madrid, 2008, Journal of pineal research.

Factor VII –323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk

G. Lip, M. Valdés, F. Marín, 2008, Annals of medicine.

Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry.

M. Monreal, V. Vicente, R. Lecumberri, 2009, Thrombosis research.

Platelet GP IIIa Polymorphism HPA-1 (PlA) Protects Against Subarachnoid Hemorrhage

J. Corral, V. Vicente, R. González-Conejero, 2004, Stroke.

Protective role of antithrombin in mouse models of liver injury.

J. Corral, V. Vicente, I. Martínez-Martínez, 2012, Journal of hepatology.

Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: clonal evolution and hierarchy revealed by next-generation sequencing

G. Soler, B. Bellosillo, V. Vicente, 2013, Journal of Hematology & Oncology.

Study of 18 functional hemostatic polymorphisms in mucocutaneous bleeding disorders

J. Corral, V. Vicente, T. Quiroga, 2010, Annals of Hematology.

Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients

J. Corral, V. Vicente, A. Miñano, 2021, Scientific reports.

Elevated thrombin generation in patients with congenital disorder of glycosylation and combined coagulation factor deficiencies

N. Boddaert, J. Corral, V. Vicente, 2019, Journal of thrombosis and haemostasis : JTH.

Effect of quercetin on platelet spreading on collagen and fibrinogen and on multiple platelet kinases.

V. Vicente, L. Navarro-Núñez, C. Martínez, 2010, Fitoterapia.

Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease.

J. Corral, V. Vicente, M. Lozano, 1998, Blood.

Genetic polymorphisms of factor VII are not associated with arterial thrombosis

J. Corral, V. Vicente, M. Lozano, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Inherited Platelet Disorders: An Updated Overview

J. González-Porras, V. Vicente, J. M. Bastida, 2021, International journal of molecular sciences.

Platelet GP Ib/IX/V complex: physiological role

J. Corral, V. Vicente, C. Martínez, 2000, Journal of Physiology and Biochemistry.

Role of the 807 C/T Polymorphism of the α2 Gene in Platelet GP Ia Collagen Receptor Expression and Function

F. Ortuño, J. Corral, V. Vicente, 1999, Thrombosis and Haemostasis.

A multimarker risk stratification approach to non‐ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro‐BNP and fibrin D‐dimer levels

A. Tello-Montoliu, F. Marín, V. Vicente, 2007, Journal of internal medicine.

Clinical and analytical relevance of the combination of prothrombin 20210A/A and factor V Leiden: results from a large family

J. Corral, V. Vicente, J. Rivera, 1999, British journal of haematology.

The prothrombin gene variant 20210A in venous and arterial thromboembolism.

J. Corral, V. Vicente, J. Rivera, 1999, Haematologica.

HPA-1 genotype in arterial thrombosis--role of HPA-1b polymorphism in platelet function.

J. Corral, V. Vicente, M. Lozano, 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Platelet aggregation through prothrombinase activation induced by non-aggregant doses of platelet agonists

J. Corral, V. Vicente, C. Martínez, 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Influence of the F12-4 C>T polymorphism on hemostatic tests

J. Corral, V. Vicente, T. Quiroga, 2010, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Prognostic value of annexin A5 −1 C/T polymorphism in a long term follow‐up after premature myocardial infarction

F. Marín, J. Corral, V. Vicente, 2007, Journal of thrombosis and haemostasis : JTH.

A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients.

F. Marín, J. Corral, V. Vicente, 2002, Blood.

Particulate Matter and Temperature: Increased Risk of Adverse Clinical Outcomes in Patients With Atrial Fibrillation.

J. Rivera‐Caravaca, F. Marín, V. Vicente, 2020, Mayo Clinic proceedings.

Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality

G. Lip, M. Valdés, M. A. Esteve-Pastor, 2018, International journal of clinical practice.

Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect

F. España, J. Corral, V. Vicente, 2016, Journal of thrombosis and haemostasis : JTH.

Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency

K. Overvad, S. Kristensen, J. Corral, 2016, Thrombosis and Haemostasis.

Systemic or Venous Thromboembolism Antithrombin Dublin ( p . Val 30 Glu ) : a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency

K. Overvad, S. Kristensen, J. Corral, 2022 .

Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia.

B. Bellosillo, V. Vicente, Arturo Pereira, 2010, Blood.

C0380: Clinical and Biochemical Consequences of Met1Ileu Mutation in Serpinc1 Gene: Generation of a Small Non-Inhibitory Antithrombin Variant without the N-Terminal Region by Use of an Alternative Initiation Codon that Has a Strong Gain-Of-Function Associated WI

K. Heimdal, I. Dybedal, F. Corrales, 2014 .

A Common Polymorphism Flanking the ATG Initiator Codon of GPIbα Does not Affect Expression and Is not a Major Risk Factor for Arterial Thrombosis

J. Corral, V. Vicente, C. Martínez, 2000, Thrombosis and Haemostasis.

Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models.

J. Yélamos, P. Parrilla, J. Corral, 2005, The American journal of pathology.

Influence of CYP 2 C 19 Polymorphisms in Platelet Reactivity and Prognosis in an Unselected Population of Non ST Elevation Acute Coronary Syndrome

M. Valdés, A. Tello-Montoliu, F. Marín, 2017 .

Influence of CYP2C19 polymorphisms in platelet reactivity and prognosis in an unselected population of non ST elevation acute coronary syndrome.

M. Valdés, A. Tello-Montoliu, F. Marín, 2012, Revista espanola de cardiologia.

Influence of CYP2C19 Polymorphisms in Platelet Reactivity and Prognosis in an Unselected Population of Non ST Elevation Acute Coronary Syndrome

M. Valdés, A. Tello-Montoliu, F. Marín, 2012 .

Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria

E. Colado, A. Órfão, V. Vicente, 2016 .

increases the risk for venous thrombosis A nonsense polymorphism in the protein Z-dependent protease inhibitor

J. González-Porras, V. Vicente, J. Souto, 2014 .

A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients.

J. González-Porras, V. Vicente, M. Álvarez‐Román, 2020, Blood cells, molecules & diseases.

Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia

J. González-Porras, V. Vicente, M. Álvarez‐Román, 2019, Scientific Reports.

Genetic Polymorphisms of Platelet Adhesive Molecules: Association with Breast Cancer Risk and Clinical Presentation

J. Corral, V. Vicente, F. Ayala, 2003, Breast Cancer Research and Treatment.

Role of factor XIII Val34Leu polymorphism in patients <45 years of age with acute myocardial infarction.

F. Marín, J. Corral, V. Vicente, 2003, The American journal of cardiology.

Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study

J. Corral, V. Vicente, P. Conesa‐Zamora, 2013, BMC Cancer.

MicroRNAs as potential regulators of platelet function and bleeding diatheses

V. Vicente, R. Teruel-Montoya, C. Martínez, 2019, Platelets.

Homozygous Deficiency of Heparin Cofactor II: Relevance of P17 Glutamate Residue in Serpins, Relationship With Conformational Diseases, and Role in Thrombosis

R. Carrell, J. Huntington, J. Aznar, 2004, Circulation.

Dexamethasone induces a heat‐stress response that ameliorates the conformational consequences on antithrombin of l‐asparaginase treatment

J. Corral, V. Vicente, I. Martínez-Martínez, 2009, Journal of thrombosis and haemostasis : JTH.

hemorrhage Polymorphisms of clotting factors modify the risk for primary intracranial

J. Corral, V. Vicente, R. González-Conejero, 2013 .

Inhibition of proteasome by bortezomib causes intracellular aggregation of hepatic serpins and increases the latent circulating form of antithrombin

J. Corral, V. Vicente, A. Ordóñez, 2008, Laboratory Investigation.

Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction.

F. Marín, J. Corral, V. Vicente, 2004, American heart journal.

Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.

G. Lip, F. Marín, J. Corral, 2004, Journal of molecular and cellular cardiology.

Leukaemic Transformation in Patients with Haematological Disease Receiving Tumour Necrosis Factor Inhibitors

V. Vicente, F. Ferrer-Marín, M. Amigo, 2012, Clinical Drug Investigation.

A novel genetic variant in PTGS1 affects N‐glycosylation of cyclooxygenase‐1 causing a dominant‐negative effect on platelet function and bleeding diathesis

J. Hernández-Rivas, T. Warner, J. González-Porras, 2020, American journal of hematology.

PTGS1 gene variations associated with bleeding and platelet dysfunction

V. Vicente, J. M. Bastida, J. Rivera, 2020, Platelets.

Intracellular retention of hepatic serpins caused by severe hyperlipidemia

J. Corral, V. Vicente, A. Miñano, 2006, Liver international : official journal of the International Association for the Study of the Liver.

[Prognostic value of tumor necrosis factor-alpha in patients with ST-segment elevation acute myocardial infarction].

V. Vicente, A. Carrillo, F. García-Almagro, 2007, Revista espanola de cardiologia.

Incidence of increased plasminogen activator inhibitor in patients with deep venous thrombosis and/or pulmonary embolism.

A. Estellés, J. Aznar, V. Vicente, 1989, Thrombosis research.

Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency

J. Corral, V. Vicente, A. Miñano, 2016, PloS one.

Thromboxane A2 receptor antagonism by flavonoids: structure-activity relationships.

V. Vicente, L. Navarro-Núñez, C. Martínez, 2009, Journal of agricultural and food chemistry.

Increased levels of citrullinated antithrombin in plasma of patients with rheumatoid arthritis and colorectal adenocarcinoma determined by a newly developed ELISA using a specific monoclonal antibody

J. Yélamos, S. Kristensen, J. Corral, 2010, Thrombosis and Haemostasis.

L-asparaginase-induced antithrombin type I deficiency: implications for conformational diseases.

J. Corral, V. Vicente, A. Miñano, 2006, The American journal of pathology.

Platelet septin complexes form rings and associate with the microtubular network

J. Corral, V. Vicente, C. Martínez, 2006, Journal of thrombosis and haemostasis : JTH.

Apigenin inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway.

M. Díaz-Ricart, G. Escolar, V. Vicente, 2008, Journal of agricultural and food chemistry.

Flavonoids inhibit the platelet TxA(2) signalling pathway and antagonize TxA(2) receptors (TP) in platelets and smooth muscle cells.

V. Vicente, L. Navarro-Núñez, J. Guerrero, 2007, British journal of clinical pharmacology.

The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease

J. Corral, V. Vicente, M. Lozano, 1997, British journal of haematology.

Differential effects of quercetin, apigenin and genistein on signalling pathways of protease‐activated receptors PAR1 and PAR4 in platelets

V. Vicente, L. Navarro-Núñez, J. Guerrero, 2009, British journal of pharmacology.

Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels

J. Corral, V. Vicente, I. Martínez-Martínez, 2009, Haematologica.

First exploratory study on the metabolome from plasma exosomes in patients with paroxysmal nocturnal hemoglobinuria.

J. E. Yuste, J. Espín, V. Vicente, 2019, Thrombosis research.

Efficacy and safety of peri-procedural bridging therapy with low molecular weight heparin in atrial fibrillation patients under vitamin K antagonists

M. A. Esteve-Pastor, J. Rivera‐Caravaca, F. Marín, 2018, QJM : monthly journal of the Association of Physicians.

Protein Z/Z‐dependent protease inhibitor (PZ/ZPI) anticoagulant system and thrombosis

J. Corral, V. Vicente, R. González-Conejero, 2007, British journal of haematology.

Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol.

G. Lip, M. Valdés, M. A. Esteve-Pastor, 2018, Clinical therapeutics.

Factor-V (Arg506 --> Gln) mutation in ischemic cerebrovascular disease.

J. Corral, V. Vicente, R. González-Conejero, 1997, Haemostasis.

Down Regulation of the Munc18b-syntaxin-11 Complex and β1-tubulin Impairs Secretion and Spreading in Neonatal Platelets

V. Vicente, J. Delgado, R. Teruel-Montoya, 2017, Thrombosis and Haemostasis.

Supportive management strategies for disseminated intravascular coagulation

M. Di Nisio, J. Thachil, V. Vicente, 2015, Thrombosis and Haemostasis.

A pilot study on the impact of congenital thrombophilia in COVID‐19

J. Corral, V. Vicente, A. Miñano, 2021, European journal of clinical investigation.

The FXIII Val34Leu polymorphism in venous and arterial thromboembolism.

J. Corral, V. Vicente, C. Martínez, 2000, Haematologica.

Polymorphisms of Platelet Adhesive Receptors: Do They Play a Role in Primary Intracerebral Hemorrhage?

J. Corral, V. Vicente, R. González-Conejero, 2003, Cerebrovascular Diseases.

Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores.

G. Lip, M. Valdés, F. Marín, 2017, Thrombosis and haemostasis.

Neutrophil extracellular traps and von Willebrand factor are allies that negatively influence COVID‐19 outcomes

J. Corral, V. Vicente, A. Miñano, 2021, Clinical and translational medicine.

Five prothrombotic polymorphisms and the prevalence of premature myocardial infarction.

F. Marín, J. Corral, V. Vicente, 2005, Haematologica.

The TFPI 536C →T Mutation Is not Associated with Increased Risk for Venous or Arterial Thrombosis

J. Corral, V. Vicente, C. Martínez, 2000, Thrombosis and Haemostasis.

Loss of high‐affinity thrombin receptors during platelet concentrate storage impairs the reactivity of platelets to thrombin

V. Vicente, M. Lozano, J. Rivera, 1997, Transfusion.

Regulatory regions of SERPINC1 gene: Identification of the first mutation associated with antithrombin deficiency

J. Corral, V. Vicente, J. Fontcuberta, 2012, Thrombosis and Haemostasis.

The JAK2 46/1 haplotype does not predispose to CALR-mutated myeloproliferative neoplasms

G. Soler, V. Vicente, A. Martinez-Perez, 2015, Annals of Hematology.

Antithrombin p.Thr147Ala: The First Founder Mutation in People of African Origin Responsible for Inherited Antithrombin Deficiency

J. Corral, V. Vicente, I. Martínez-Martínez, 2020, Thrombosis and Haemostasis.

Transient desialylation in combination with a novel antithrombin deficiency causing a severe and recurrent thrombosis despite anticoagulation therapy

J. Corral, V. Vicente, D. Lefeber, 2017, Scientific Reports.

AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms

J. González-Porras, F. España, A. Estellés, 2008, Haematologica.

[Effect of the early administration of pravastatin on C-reactive protein and interleukin-6 levels in the acute phase of myocardial infarction with ST segment elevation].

V. Vicente, M. Lozano, J. A. Ruiz Ros, 2004, Revista espanola de cardiologia.

Mutations in the shutter region of antithrombin result in formation of disulfide‐linked dimers and severe venous thrombosis

R. Carrell, J. Huntington, J. Corral, 2004, Journal of thrombosis and haemostasis : JTH.

Gamma-glutamyl carboxylase R325Q polymorphism on the response of acenocoumarol.

J. Corral, V. Vicente, V. Roldán, 2008, Thrombosis research.

The genetic interaction between VKORC1 c1173t and calumenin a29809g modulates the anticoagulant response of acenocoumarol

F. Marín, J. Corral, V. Vicente, 2007, Journal of thrombosis and haemostasis : JTH.

Latent and Polymeric Antithrombin: Clearance and Potential Thrombotic Risk

J. Corral, V. Vicente, L. Navarro-Núñez, 2007, Experimental biology and medicine.

Impaired leucocyte activation is underlining the lower thrombotic risk of essential thrombocythaemia patients with CALR mutations as compared with those with the JAK2 mutation

V. Vicente, C. Martínez, F. Ferrer-Marín, 2016, British journal of haematology.

Factor XIII Val34Leu polymorphism in primary intracerebral haemorrhage.

J. Corral, V. Vicente, J. Rivera, 2000, The hematology journal : the official journal of the European Haematology Association.

Evaluation of refrigerated platelet concentrates supplemented with low doses of second messenger effectors.

J. Corral, V. Vicente, J. Guerrero, 2004, Clinical and laboratory haematology.

Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site

J. Corral, V. Vicente, I. Martínez-Martínez, 2016, PloS one.

Nonsense Mutation in Exon-19 of GPIIb Associated with Thrombasthenic Phenotype. Failure of GPIIb(Δ597-1008) to Form Stable Complexes with GPIIIa

V. Vicente, E. G. Arias-Salgado, N. Butta, 2002, Thrombosis and Haemostasis.

Proteomic analysis of platelet N-glycoproteins in PMM2-CDG patients.

M. Di Michele, J. Corral, V. Vicente, 2014, Thrombosis research.

Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients.

G. Lip, M. Valdés, M. A. Esteve-Pastor, 2017, International journal of cardiology.

Neutrophil extracellular trap components increase the expression of coagulation factors.

V. Vicente, N. García-Barberá, C. Martínez, 2019, Biomedical reports.

L718P mutation in the membrane-proximal cytoplasmic tail of β3 promotes abnormal αIIbβ3 clustering and lipid microdomain coalescence, and associates with a thrombasthenia-like phenotype

P. Lastres, V. Vicente, C. Martínez, 2010, Haematologica.

Role of Factor Xiii Val 34 Leu Polymorphism in Patients with Migraine

J. Corral, V. Vicente, R. González-Conejero, 2001, Cephalalgia : an international journal of headache.

Deep venous thrombosis or pulmonary embolism and factor V Leiden: enigma or paradox

J. Corral, V. Vicente, V. Roldán, 2010, Haematologica.

AssociationofAnthracycline-RelatedCardiacHistological LesionsWith NADPHOxidaseFunctionalPolymorphisms

Vega, J. Corral, V. Vicente, 2013 .

Expanding the genetic spectrum of TUBB1-related thrombocytopenia

V. Vicente, P. Gresele, L. Bury, 2021, Blood advances.

Activated protein C:α1-antitrypsin (APC:α1AT) complex as a marker for in vitro diagnosis of prethrombotic states

J. Gilabert, F. España, A. Estellés, 1992 .

Congenital antithrombin deficiency in patients with splanchnic vein thrombosis

J. Corral, V. Vicente, J. García‐Pagán, 2019, Liver international : official journal of the International Association for the Study of the Liver.

JAK2 V617F, hemostatic polymorphisms, and clinical features as risk factors for arterial thrombotic events in essential thrombocythemia

B. Bellosillo, V. Vicente, L. Navarro-Núñez, 2008, Annals of Hematology.

Nonsense mutation in the glycoprotein Iba coding sequence associated with Bernard-Soulier syndrome (platelet receptor/thrombosis/bleeding disorder/platelet adhesion/thrombocytopenia)

S. Russell, J. Ware, V. Vicente, 2016 .

Dexamethasone induction of a heat stress response.

J. Corral, V. Vicente, J. Guerrero, 2011, Methods in enzymology.

Binding of Recombinant Apolipoprotein(a) to Human Platelets and Effect on Platelet Aggregation

J. Corral, V. Vicente, E. Angles-cano, 2001, Thrombosis and Haemostasis.

Long-Read Sequencing Identifies the First Retrotransposon Insertion and Resolves Structural Variants Causing Antithrombin Deficiency

Nicholas S. Gleadall, W. Ouwehand, P. Morange, 2022, Thrombosis and haemostasis.

Long-Read Sequencing Identi ﬁ es the First Retrotransposon Insertion and Resolves Structural Variants Causing Antithrombin De ﬁ ciency

Nicholas S. Gleadall, W. Ouwehand, P. Morange, 2022 .

Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease.

J. Griffin, F. España, V. Vicente, 1990, Thrombosis research.

Migraine and Prothrombotic Genetic Risk Factors

J. Corral, V. Vicente, M. Lozano, 1998, Cephalalgia : an international journal of headache.

Detection of Factor V Leiden from a Drop of Blood by PCR-SSCP

J. Corral, V. Vicente, R. González-Conejero, 1996, Thrombosis and Haemostasis.

Synergistic association between hypercholesterolemia and the C46T factor XII polymorphism for developing premature myocardial infarction

F. Marín, J. Corral, V. Vicente, 2005, Thrombosis and Haemostasis.

Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G/5G polymorphism.

E. Solá, L. Ramón, F. España, 2008, Thrombosis research.

In vitro analysis of platelet concentrates stored in the presence of modulators of 3',5' adenosine monophosphate, and organic anions.

J. Corral, V. Vicente, E. Bermejo, 2000, Transfusion science.

[New oral anticoagulants: a multidisciplinary approach].

D. Jiménez, M. Monreal, V. Vicente, 2009, Medicina clinica.

Effect of factor VII −323 Del/Ins polymorphism on the daily variability of factor VIIc and INR in steady anticoagulated patients with acenocoumarol

F. Marín, J. Corral, V. Vicente, 2004, Journal of thrombosis and haemostasis : JTH.

Implications for Conformational Diseases

J. Corral, V. Vicente, I. Heras, 2006 .

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera.

B. Bellosillo, V. Vicente, Arturo Pereira, 2012, Blood.

Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia

S. Watson, V. Vicente, J. Delgado, 2018, Thrombosis and Haemostasis.

Factors with conformational effects on haemostatic serpins: Implications in thrombosis

J. Corral, V. Vicente, A. Ordóñez, 2007, Thrombosis and Haemostasis.

Evaluation of Novel Platelet Polymorphisms in Stroke. Dichotomic Effect of rs5443 in GNB3

J. Corral, V. Vicente, C. Martínez, 2015, Journal of clinical neurology.

A radioreceptor assay for mass measurement of inositol (1,4,5)-trisphosphate using saponin-permeabilized outdated human platelets.

J. Corral, V. Vicente, F. de Arriba, 1998, Analytical biochemistry.

Genotype–phenotype relationship for six common polymorphisms in genes affecting platelet function from 286 healthy subjects and 160 patients with mucocutaneous bleeding of unknown cause

J. Corral, V. Vicente, L. Navarro-Núñez, 2009, British journal of haematology.

Congenital disorder of glycosylation (PMM2‐CDG) in a patient with antithrombin deficiency and severe thrombophilia

J. Corral, V. Vicente, J. Jaeken, 2012, Journal of thrombosis and haemostasis : JTH.

Platelet activation and neutrophil extracellular trap (NET) formation in immune thrombocytopenia: is there an association?

V. Vicente, L. Garabet, N. García-Barberá, 2019, Platelets.

Activation of the protein C pathway in acute sepsis.

F. España, A. Estellés, J. Aznar, 1995, Thrombosis research.

Fibrinolytic changes during acute vascular damage induced by Mediterranean spotted fever

F. España, A. Estellés, J. Aznar, 1993 .

Evidence of activation of the protein C pathway during acute vascular damage induced by Mediterranean spotted fever.

J. Griffin, F. España, A. Estellés, 1991, Blood.

Complex formation between protein c inhibitor and tissue plasminogen activator during thrombolytic therapy: Evidence of activation of protein C pathway

F. España, A. Estellés, J. Aznar, 1993 .

ABO blood group does not increase the risk of thrombosis in Philadelphia-negative myeloproliferative disorders.

B. Bellosillo, V. Vicente, C. Besses, 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Antithrombin is incorporated into exosomes produced by antithrombin non-expressing cells.

V. Vicente, M. Quintanilla, I. Martínez-Martínez, 2019, Biochimie.

Nonsense mutation in the glycoprotein Ib alpha coding sequence associated with Bernard-Soulier syndrome.

S. Russell, J. Ware, V. Vicente, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Hereditary thrombophilia: identification of nonsense and missense mutations in the protein C gene.

C. Peschle, R. Bertina, V. Vicente, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Prothrombin A19911G and G20210A polymorphisms' role in thrombosis

J. Corral, V. Vicente, A. Vayá, 2002, British journal of haematology.

Detection of conformational transformation of antithrombin in blood with crossed immunoelectrophoresis: new application for a classical method.

J. Corral, V. Vicente, A. Miñano, 2003, The Journal of laboratory and clinical medicine.

Effects of oral anticoagulant therapy and haplotype 1 of the endothelial protein C receptor gene on activated protein C levels

R. Bertina, F. España, A. Estellés, 2012, Thrombosis and Haemostasis.

Association of the Thrombomodulin Gene c.1418C>T Polymorphism With Thrombomodulin Levels and With Venous Thrombosis Risk

R. Bertina, F. España, A. Estellés, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Evaluation of a new whole‐blood filter that allows preparation of platelet concentrates by platelet‐rich plasma methods

V. Vicente, M. Lozano, J. Rivera, 2003, Transfusion.

Guidelines of the Spanish ITP Group for the diagnosis, treatment and follow-up of patients with immune thrombopenia.

M. Sanz, V. Vicente, M. Lozano, 2021, Medicina clinica.

Prothrombotic Genetic Risk Factors in Patients With Coexisting Migraine and Ischemic Cerebrovascular Disease

J. Corral, V. Vicente, J. Rivera, 1999, Headache.

Portal and mesenteric venous thrombosis in a patient heterozygous for the 20210 A allele of the prothrombin gene.

J. Corral, V. Vicente, R. González-Conejero, 1998, Haematologica.

Towards the targeted management of Chediak-Higashi syndrome

V. Vicente, M. Lozano, J. Rivera, 2014, Orphanet Journal of Rare Diseases.

Role of the C‐sheet in the maturation of N‐glycans on antithrombin: functional relevance of pleiotropic mutations

J. Corral, V. Vicente, R. Gutiérrez-Gallego, 2014, Journal of thrombosis and haemostasis : JTH.

Effects of acrolein, a natural occurring aldehyde, on the anticoagulant serpin antithrombin

S. Kristensen, J. Corral, V. Vicente, 2009, FEBS letters.

Hermansky-Pudlak syndrome

V. Vicente, M. Lozano, J. Rivera, 2014, Hämostaseologie.

Platelet cryopreservation using a reduced dimethyl sulfoxide concentration and second-messenger effectors as cryopreserving solution.

J. Corral, V. Vicente, M. Lozano, 1999, Cryobiology.

Gynaecological and obstetrical bleeding in Caucasian women with congenital factor XI deficiency: Results from a twenty-year, retrospective, observational study.

J. Corral, V. Vicente, A. Miñano, 2019, Medicina clinica.

In Vitro Changes of Platelet Parameters

V. Vicente, M. Lozano, J. Rivera, 2004 .

Association of polymorphisms in TRAIL1 and TRAILR1 genes with susceptibility to lymphomas

V. Vicente, P. Conesa‐Zamora, R. González-Conejero, 2014, Annals of Hematology.

Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex.

Luigi, F. Fabris, V. Vicente, 1990, The Journal of clinical investigation.

Evaluation of four rapid methods for hemoglobin screening of whole blood donors in mobile collection settings.

J. Corral, V. Vicente, L. Navarro-Núñez, 2007, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy.

J. Corral, V. Vicente, V. Pérez-Andreu, 2009, Blood.

Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor

V. Vicente, J. Guerrero, M. Lozano, 2005, Journal of thrombosis and haemostasis : JTH.

Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells

D. Cheresh, V. Vicente, Z. Ruggeri, 1989, Cell.

Platelet receptors and signaling in the dynamics of thrombus formation

V. Vicente, L. Navarro-Núñez, M. Lozano, 2009, Haematologica.

Identification of novel variants in ten patients with Hermansky-Pudlak syndrome by high-throughput sequencing

J. Hernández-Rivas, Jorge Oliveira, J. González-Porras, 2019, Annals of medicine.

Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content

J. González-Porras, J. Corral, V. Vicente, 2018, Platelets.

Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding.

R. Houghten, V. Vicente, Z. Ruggeri, 1990, The Journal of biological chemistry.

Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells

C. Plasencia, V. Vicente, I. Martínez-Martínez, 2021, Biomedicines.

Functional and molecular characterization of inherited platelet disorders in the Iberian Peninsula: results from a collaborative study

V. Vicente, A. Cid, M. Lozano, 2014, Orphanet Journal of Rare Diseases.

Potential Role of miRNAs in Developmental Haemostasis

J. Corral, V. Vicente, V. Pérez-Andreu, 2011, PloS one.

Regulation of Coagulation Factor XI Expression by MicroRNAs in the Human Liver

E. Schuetz, V. Vicente, R. Teruel-Montoya, 2014, PloS one.

Qualitative and Quantitative Comparison of Plasma Exosomes from Neonates and Adults

Ángel García, V. Vicente, S. Bravo, 2021, International journal of molecular sciences.

Isolation and functional characterization of the von Willebrand factor-binding domain located between residues His1-Arg293 of the alpha-chain of glycoprotein Ib.

V. Vicente, Z. Ruggeri, P. Kostel, 1988, The Journal of biological chemistry.

Genetic variants of the extra‐large stimulatory Gs protein alpha‐subunit and risk of thrombotic and haemorrhagic disorders

J. Corral, V. Vicente, J. Guerrero, 2004, British journal of haematology.

Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene.

P. Real, V. Vicente, V. Ramos-Mejia, 2016, Stem cell research.

Mutation analysis of HPS1, the gene mutated in Hermansky-Pudlak syndrome, in patients with isolated platelet dense-granule deficiency.

J. Corral, V. Vicente, P. Doménech, 2004, Haematologica.

Wiskott–Aldrich syndrome in a child presenting with macrothrombocytopenia

M. Pérez‐Andrés, Elena Blanco, V. Vicente, 2017, Platelets.

An atypical IgM class platelet cold agglutinin induces GPVI-dependent aggregation of human platelets

S. Watson, V. Vicente, I. Martínez-Martínez, 2015, Thrombosis and Haemostasis.

A. Greinacher, V. Vicente, C. Zaninetti, 2022, Blood advances.

Allogeneic hematopoietic cell transplantation in an adult patient with Glanzmann thrombasthenia

M. Sanz, V. Vicente, J. Sanz, 2017, Clinical case reports.

Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders

J. Hernández-Rivas, S. Watson, J. González-Porras, 2017, Haematologica.

Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction.

David S. Paul, J. Hernández-Rivas, S. Watson, 2016, Blood.

Chediak–Higashi syndrome: description of two novel homozygous missense mutations causing divergent clinical phenotype

F. Ortuño, V. Vicente, N. García-Barberá, 2014, European journal of haematology.

Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution.

V. Vicente, F. Ferrer-Marín, M. Lozano, 2018, Blood transfusion = Trasfusione del sangue.

microRNAs in the haemostatic system: More than witnesses of thromboembolic diseases?

V. Vicente, R. Teruel-Montoya, C. Martínez, 2018, Thrombosis research.

miR-146a in Cardiovascular Diseases and Sepsis: An Additional Burden in the Inflammatory Balance?

V. Vicente, C. Martínez, R. González-Conejero, 2020, Thrombosis and Haemostasis.

Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage.

J. Corral, V. Vicente, R. González-Conejero, 2001, Blood.

Frozen and cold-stored platelets: reconsidered platelet products

V. Vicente, A. Castrillo, J. Rivera, 2021, Platelets.

Biallelic Mutations in KDSR Disrupt Ceramide Synthesis and Result in a Spectrum of Keratinization Disorders Associated with Thrombocytopenia

D. Kelsell, M. Simpson, M. Akiyama, 2017, Journal of Investigative Dermatology.

Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores

G. Lip, F. Marín, V. Vicente, 2017, Thrombosis and Haemostasis.

Incidence and features of thrombosis in children with inherited antithrombin deficiency

J. Corral, V. Vicente, K. Jochmans, 2019, Haematologica.

Management of antithrombin deficiency: an update for clinicians

J. Corral, V. Vicente, C. Bravo-Pérez, 2019, Expert review of hematology.

Full-length antithrombin frameshift variant with aberrant C-terminus causes endoplasmic reticulum retention with a dominant-negative effect

J. Corral, V. Vicente, S. Marciniak, 2022, JCI insight.

Molecular dissection of structural variations involved in antithrombin deficiency.

W. Ouwehand, J. Hernández-Rivas, J. Corral, 2022, The Journal of molecular diagnostics : JMD.

Identification of a New Mechanism of Antithrombin Deficiency Hardly Detected by Current Methods: Duplication of SERPINC1 Exon 6

J. Corral, V. Vicente, A. Miñano, 2018, Thrombosis and Haemostasis.

The number of platelet glycoprotein Ia molecules is associated with the genetically linked 807 C/T and HPA‐5 polymorphisms

J. Corral, V. Vicente, J. Rivera, 1999, Transfusion.

High on-treatment platelet reactivity in patients with ischemic cerebrovascular disease: assessment of prevalence and stability over time using four platelet function tests

V. Vicente, C. Martínez, E. Jover, 2014, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis.

J. González-Porras, J. Corral, V. Vicente, 2007, Blood.

High levels of latent antithrombin in plasma from patients with antithrombin deficiency

J. Corral, V. Vicente, P. Llamas, 2017, Thrombosis and Haemostasis.

A new method to quantify β-antithrombin glycoform in plasma reveals increased levels during the acute stroke event.

J. Corral, V. Vicente, I. Martínez-Martínez, 2015, Thrombosis research.

Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism.

S. Kristensen, J. Corral, V. Vicente, 2012, Blood.

Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis

F. España, A. Estellés, F. Marín, 2009, Thrombosis and Haemostasis.

The genetics of antithrombin.

J. Corral, V. Vicente, M. E. de la Morena-Barrio, 2018, Thrombosis research.

Puzzling questions on antithrombin: Diagnostic limitations and real incidence in venous and arterial thrombosis.

J. Corral, V. Vicente, 2015, Thrombosis research.

N-Glycosylation as a Tool to Study Antithrombin Secretion, Conformation, and Function

J. Corral, V. Vicente, I. Martínez-Martínez, 2021, International journal of molecular sciences.

Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase

J. Corral, V. Vicente, M. Quintanilla, 2016, Scientific Reports.

Type II antithrombin deficiency caused by a large in‐frame insertion: structural, functional and pathological relevance

J. Huntington, J. Corral, V. Vicente, 2012, Journal of thrombosis and haemostasis : JTH.

The Infective Polymerization of Conformationally Unstable Antithrombin Mutants May Play a Role in the Clinical Severity of Antithrombin Deficiency

J. Corral, V. Vicente, I. Martínez-Martínez, 2012, Molecular medicine.

Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation

J. Corral, V. Vicente, R. Gutiérrez-Gallego, 2010, Haematologica.

Hyperglycaemia impairs antithrombin secretion: possible contribution to the thrombotic risk of diabetes.

J. Corral, V. Vicente, I. Martínez-Martínez, 2009, Thrombosis research.

Molecular and clinical characterization of transient antithrombin deficiency: A new concept in congenital thrombophilia

J. Corral, V. Vicente, A. Miñano, 2021, American journal of hematology.

Regulatory regions of SERPINC1 gene: Identification of the first mutation associated with antithrombin deficiency

J. Corral, V. Vicente, J. Fontcuberta, 2012, Thrombosis and Haemostasis.

Thrombosis as a conformational disease.

R. Carrell, J. Corral, V. Vicente, 2005, Haematologica.

Usefulness and Limitations of Multiple Ligation-Dependent Probe Amplification in Antithrombin Deficiency

J. Corral, V. Vicente, A. Miñano, 2023, International journal of molecular sciences.

Identification of the first large intronic deletion responsible of type I antithrombin deficiency not detected by routine molecular diagnostic methods

J. Corral, V. Vicente, F. Vidal, 2019, British journal of haematology.

Defects of splicing in antithrombin deficiency

J. Corral, V. Vicente, I. Martínez-Martínez, 2017, Research and practice in thrombosis and haemostasis.

A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis.

J. González-Porras, J. Corral, V. Vicente, 2006, Blood.

Thrombin in the Activation of the Fluid Contact Phase in Patients with Hereditary Angioedema Carrying the F12 P.Thr309Lys Variant

M. López-Trascasa, J. Emsley, J. Corral, 2021, Clinical Reviews in Allergy & Immunology.

The FXII c.-4T>C Polymorphism as a Disease Modifier in Patients With Hereditary Angioedema Due to the FXII p.Thr328Lys Variant

M. López-Trascasa, J. Emsley, J. Corral, 2020, Frontiers in Genetics.

Factor XII in PMM2-CDG patients: role of N-glycosylation in the secretion and function of the first element of the contact pathway

J. Emsley, J. Corral, V. Vicente, 2020, Orphanet Journal of Rare Diseases.

Novel loci involved in platelet function and platelet count identified by a genome-wide study performed in children

J. Corral, V. Vicente, J. Soria, 2011, Haematologica.

An early increase of CD56bright natural killer subset as dominant effect and predictor of response to extracorporeal photopheresis for graft‐versus‐host disease

A. Hurtado, T. Chen-Liang, A. Jerez, 2018, Transfusion.

Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study

J. Corral, V. Vicente, P. Conesa‐Zamora, 2013, BMC Cancer.

Regulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens

J. Hansen, V. Vicente, C. López-Pedrera, 2017, Scientific Reports.

Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation

J. Rivera‐Caravaca, V. Vicente, F. de Arriba, 2018, Hematology.

Comprehensive comparison of neonate and adult human platelet transcriptomes

V. Vicente, R. Teruel-Montoya, C. Martínez, 2017, PloS one.

Uniparental disomy causes deficiencies of vitamin K‐dependent proteins

J. Corral, V. Vicente, N. García-Barberá, 2016, Journal of thrombosis and haemostasis : JTH.

Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation.

G. Lip, S. Manzano-Fernández, E. Orenes-Piñero, 2015, Revista espanola de cardiologia.

RASGRP2 gene variations associated with platelet dysfunction and bleeding

V. Vicente, J. M. Bastida, M. Lozano, 2019, Platelets.

Identification of two novel mutations in RASGRP2 affecting platelet CalDAG-GEFI expression and function in patients with bleeding diathesis

David S. Paul, J. Hernández-Rivas, S. Watson, 2017, Platelets.

Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project

J. Rivera‐Caravaca, F. Marín, V. Vicente, 2020, Thrombosis and Haemostasis.

Prediction of long‐term net clinical outcomes using the TIMI‐AF score: Comparison with CHA2DS2‐VASc and HAS‐BLED

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2018, American heart journal.

Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).

G. Lip, S. Manzano-Fernández, F. Marín, 2013, The American journal of cardiology.

MiR-146a Regulates Neutrophil Extracellular Trap Formation That Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation

J. Rivera‐Caravaca, V. Vicente, N. García-Barberá, 2018, Arteriosclerosis, thrombosis, and vascular biology.

Long‐Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC‐Stroke and CHA 2 DS 2‐VASc Scores

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2017, Journal of the American Heart Association.

The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.

G. Lip, S. Manzano-Fernández, F. Marín, 2013, Journal of the American College of Cardiology.

Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores.

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2019, Stroke.

Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

G. Lip, J. Rivera‐Caravaca, F. Marín, 2017, Scientific Reports.

Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2018, European journal of clinical investigation.

Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA2DS2-VASc and HAS-BLED scores using multiple biomarkers

M. A. Esteve-Pastor, J. Rivera‐Caravaca, F. Marín, 2018, Annals of medicine.

The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.

G. Lip, F. Marín, V. Vicente, 2015, The American journal of medicine.

SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation.

G. Lip, F. Marín, V. Vicente, 2014, The American journal of medicine.

Usefulness of N-Terminal Pro–B-Type Natriuretic Peptide Levels for Stroke Risk Prediction in Anticoagulated Patients With Atrial Fibrillation

G. Lip, S. Manzano-Fernández, F. Marín, 2014, Stroke.

Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

G. Lip, F. Marín, V. Vicente, 2013, Thrombosis and Haemostasis.

The prognostic role of the adiponectin levels in atrial fibrillation

S. Manzano-Fernández, F. Marín, V. Vicente, 2013, European journal of clinical investigation.

Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation

G. Lip, F. Marín, V. Vicente, 2012, Circulation. Arrhythmia and electrophysiology.

Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation

M. A. Esteve-Pastor, J. Rivera‐Caravaca, F. Marín, 2019, BMJ Open.

Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation.

Á. Cequier, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2017, The American journal of cardiology.

Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2017, Thrombosis and Haemostasis.

Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation

S. Manzano-Fernández, F. Marín, V. Vicente, 2014, Thrombosis and Haemostasis.

Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation

S. Manzano-Fernández, F. Marín, V. Vicente, 2012, European journal of clinical investigation.

High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation

S. Manzano-Fernández, F. Marín, V. Vicente, 2012, Journal of thrombosis and haemostasis : JTH.

Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.

G. Lip, F. Marín, V. Vicente, 2012, Revista espanola de cardiologia.

Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.

F. Marín, V. Vicente, G. Lip, 2011, Journal of the American College of Cardiology.

Effect of Factor XIII VAL34LEU Polymorphism on Thrombolytic Therapy in Premature Myocardial Infarction

F. Marín, J. Corral, V. Vicente, 2002, Thrombosis and Haemostasis.

A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.

G. Lip, F. Marín, J. Corral, 2005, Journal of the American College of Cardiology.

A cytologic study of the sediments in pericardial fluid as it relates to a diagnosis of the mechanism of death

V. Vicente, E. Osuna, A. Luna, 2004, Zeitschrift für Rechtsmedizin.

Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea

B. Bellosillo, V. Vicente, F. Cervantes, 2014, Annals of Hematology.

β-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment.

G. Lip, S. Manzano-Fernández, F. Marín, 2013, Chest.

MiRNA-Based Regulation of Hemostatic Factors through Hepatic Nuclear Factor-4 Alpha

V. Vicente, R. Teruel-Montoya, N. García-Barberá, 2016, PloS one.

Assessment of two contact activation reagents for the diagnosis of congenital factor XI deficiency.

J. Corral, V. Vicente, A. Miñano, 2018, Thrombosis research.

Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome

J. Corral, V. Vicente, C. López-Pedrera, 2011, Journal of thrombosis and haemostasis : JTH.

Successful mobilization of hematopoietic peripheral blood progenitor cells with paclitaxel-based chemotherapy as initial or salvage regimen in patients with hematologic malignancies

V. Vicente, F. de Arriba, M. Lozano, 2008, Haematologica.

Protein Z‐dependent protease inhibitor W303X mutation in venous thrombosis

J. Corral, V. Vicente, R. González-Conejero, 2005, British journal of haematology.

Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.

F. Marín, V. Vicente, F. Ruíz-Espejo, 2008, American heart journal.

High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: Description of a new syndrome

J. Corral, V. Vicente, A. Miñano, 2021, American journal of hematology.

MicroRNAs as New Regulators of Neutrophil Extracellular Trap Formation

V. Vicente, C. Martínez, R. González-Conejero, 2021, International journal of molecular sciences.

Plasma angiogenin levels in acute coronary syndromes: implications for prognosis.

G. Lip, A. Tello-Montoliu, F. Marín, 2007, European heart journal.

TUBB1 Q43P polymorphism does not protect against acute coronary syndrome and premature myocardial infarction

F. Marín, V. Vicente, C. Martínez, 2008, Thrombosis and Haemostasis.

Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.

J. Gilabert-Estellés, A. Braza-Boïls, A. Estellés, 2015, Human reproduction.

Effect of VKORC1, CYP2C9 and CYP4F2 genetic variants in early outcomes during acenocoumarol treatment.

J. Corral, V. Vicente, N. García-Barberá, 2014, Pharmacogenomics.

Coexistence of three genetic risk factors in a Spanish thrombophilic family: Factor V Leiden, prothrombin 20210 and a new type I antithrombin deficiency

J. Corral, V. Vicente, A. Ordóñez, 2006, Thrombosis and Haemostasis.

miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis

V. Vicente, V. Andrés, C. Martínez, 2020, Haematologica.

A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real‐World” vs Clinical Trials

G. Lip, J. Rivera‐Caravaca, F. Marín, 2018, Mayo Clinic proceedings.

Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project

J. Rivera‐Caravaca, F. Marín, V. Vicente, 2018, Journal of General Internal Medicine.

GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients

S. Kristensen, J. Corral, V. Vicente, 2013, Orphanet Journal of Rare Diseases.

Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines

J. González-Porras, V. Vicente, M. Álvarez, 2016, Annals of Hematology.

Prediction of long-term net clinical outcomes using the TIMI-AF score : Comparison with CHA 2 DS 2-VASc and HAS-BLED Cover title : Prediction of net clinical outcomes by the TIMI-AF

G. Lip, J. Rivera‐Caravaca, V. Vicente, 2017 .

Underlying disorders of disseminated intravascular coagulation: Communication from the ISTH SSC Subcommittees on Disseminated Intravascular Coagulation and Perioperative and Critical Care Thrombosis and Hemostasis

M. Di Nisio, V. Vicente, O. Erez, 2020, Journal of thrombosis and haemostasis : JTH.

Usefulness of the 2 MACE score to predicts adverse cardiovascular events in patients with atrial fibrillation

Á. Cequier, J. Rivera‐Caravaca, F. Marín, 2017 .

Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.

G. Lip, S. Manzano-Fernández, F. Marín, 2013, Chest.

Role of GSTT1 and M1 null genotypes as risk factors for B‐cell lymphoma: Influence of geographical factors and occupational exposure

V. Vicente, P. Conesa‐Zamora, R. González-Conejero, 2012, Molecular carcinogenesis.

miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk

B. Bellosillo, V. Vicente, C. Fernández-Rodríguez, 2020, Leukemia.

Genotype-guided therapy improves initial acenocoumarol dosing

J. Corral, V. Vicente, V. Roldán, 2016, Thrombosis and Haemostasis.

ALG12‐CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant

J. Corral, V. Vicente, A. Miñano, 2020, Molecular genetics & genomic medicine.

miR-133a Regulates Vitamin K 2,3-Epoxide Reductase Complex Subunit 1 (VKORC1), a Key Protein in the Vitamin K Cycle

P. Deloukas, J. Corral, V. Vicente, 2012, Molecular Medicine.

When genetic and surname analyses meet historical sources: The C56R mutation associated with factor XI deficiency as a marker of human migration during the Spanish Reconquista.

J. Corral, V. Vicente, F. Bauduer, 2020, Medical hypotheses.

Archeogenetics of F11 p.Cys38Arg: a 5400-year-old mutation identified in different southwestern European countries.

J. Corral, V. Vicente, F. Bauduer, 2019, Blood.

Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation

J. Rivera‐Caravaca, F. Marín, V. Vicente, 2020, Journal of clinical medicine.

Synergism between factor XII –4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

G. Lip, F. Marín, J. Corral, 2010, Thrombosis and Haemostasis.

sST2 levels are associated with all‐cause mortality in anticoagulated patients with atrial fibrillation

S. Manzano-Fernández, F. Marín, V. Vicente, 2015, European journal of clinical investigation.

Genotype–phenotype gradient of SERPINC1 variants in a single family reveals a severe compound antithrombin deficiency in a dead embryo

J. Corral, V. Vicente, A. Miñano, 2020, British Journal of Haematology.

Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients

J. Corral, V. Vicente, A. Miñano, 2020, Scientific Reports.

Anticoagulant therapy in patients with congenital FXI deficiency

J. Corral, V. Vicente, A. Miñano, 2021, Blood advances.

Rare homozygous status of P43 β1-tubulin polymorphism causes alterations in platelet ultrastructure

P. Nurden, J. Corral, V. Vicente, 2011, Thrombosis and Haemostasis.

Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays

D. Trégouët, P. Morange, J. Deleuze, 2022, Blood.

Novel Associations of VKORC1 Variants with Higher Acenocoumarol Requirements

J. Corral, V. Vicente, V. Pérez-Andreu, 2013, PloS one.

Detection of free hepatitis C virus core antigen by enzyme‐linked immunosorbent assay is not suitable for screening of granulocyte colony‐stimulating factor‐mobilized hematopoietic progenitor donors

V. Vicente, M. Lozano, I. Zuazu, 2004, Transfusion.

Genetic determinants of platelet function in thromboembolic diseases.

J. Corral, V. Vicente, R. González-Conejero, 2004, Journal of Biological Regulators and Homeostatic Agents.

Biological dosimetry and Bayesian analysis of chromosomal damage in thyroid cancer patients.

V. Vicente, Vicente Vicente, Miguel Alcaraz, 2007, Radiation protection dosimetry.

High incidence of FXI deficiency in a Spanish town caused by 11 different mutations and the first duplication of F11: Results from the Yecla study

J. Corral, V. Vicente, F. Vidal, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Inherited thrombophilic conditions

J. Corral, V. Vicente, 2012, Hematology.

miR-146a deficiency in hematopoietic cells is not involved in the development of atherosclerosis

V. Vicente, V. Andrés, N. García-Barberá, 2018, PloS one.

Role of Fibrinogen Levels and Factor XIII V34L Polymorphism in Thrombolytic Therapy in Stroke Patients

J. Montaner, J. Álvarez-Sabín, J. Martí-Fàbregas, 2006, Stroke.

Compound heterozygosity involving Antithrombin Cambridge II (p.Ala416Ser) in antithrombin deficiency

J. Corral, V. Vicente, P. Llamas, 2013, Thrombosis and Haemostasis.

New alleles of the platelet glycoprotein Ibalpha gene.

J. Corral, V. Vicente, M. Lozano, 1998, British Journal of Haematology.

Identification of Antithrombin-Modulating Genes. Role of LARGE, a Gene Encoding a Bifunctional Glycosyltransferase, in the Secretion of Proteins?

A. Buil, J. Corral, V. Vicente, 2013, PloS one.

Developmental Differences in Platelet Inhibition Response to Prostaglandin E1

V. Vicente, R. Teruel-Montoya, A. Begonja, 2019, Neonatology.

Molecular, ultrastructural and functional characterization of a Spanish family with Hermansky–Pudlak syndrome: role of insC974 in platelet function and clinical relevance

G. Escolar, J. Corral, V. Vicente, 2003, British journal of haematology.

Induced pluripotent stem cells derived from Bernard-Soulier Syndrome patient's peripheral blood cells with a p.Phe55Ser mutation in the GPIX gene.

P. Real, V. Vicente, V. Ramos-Mejia, 2017, Stem Cell Research.

Generation of a human induced pluripotent stem cell (iPSC) line from a Bernard-Soulier syndrome patient with the mutation p.Asn45Ser in the GPIX gene.

P. Real, V. Vicente, V. Ramos-Mejia, 2016, Stem cell research.

Evaluation of Leukocyte‐Depleted Platelet Concentrates Obtained by In‐Line Filtration

J. Corral, V. Vicente, J. Rivera, 2000, Vox Sanguinis.

Association of autoantibodies against platelet glycoproteins Ib/IX and IIb/IIIa, and platelet‐reactive anti‐HIV antibodies in thrombocytopenic narcotic addicts

V. Vicente, J. Rivera, A. Cano, 1996, British journal of haematology.

Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation

G. Lip, J. Rivera‐Caravaca, F. Marín, 2017, Scientific Reports.

In vitro changes of platelet parameters: lessons from blood banking.

V. Vicente, M. Lozano, J. Rivera, 2004, Methods in molecular biology.

Hemostasis, Thrombosis, and Vascular Biology

J. Corral, V. Vicente, J. Fontcuberta, 2006 .

Inherited Platelet Disorders: An Updated Overview

J. González-Porras, V. Vicente, M. Lozano, 2021, International Journal of Molecular Sciences.

Congenital FXI deficiency and risk of heart failure in humans.

J. Corral, V. Vicente, A. Miñano, 2023, Journal of thrombosis and haemostasis : JTH.

CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis

J. Ruiz-Nodar, A. Tello-Montoliu, F. Marín, 2010, Annals of medicine.

Genetic predisposition to fetal alcohol syndrome: association with congenital disorders of N-glycosylation

M. Campo, J. Corral, V. Vicente, 2018, Pediatric Research.

Factor VIII half-life and intensity of treatment in hemophilic patients.

V. Vicente, 2005, Haematologica.

Biallelic Mutations in KDSR Disrupt Ceramide Synthesis and Result in a Spectrum of Keratinization Disorders Associated with Thrombocytopenia

D. Kelsell, M. Simpson, M. Akiyama, 2017, The Journal of investigative dermatology.

Pharmacogenetics of acenocoumarol in patients with extreme dose requirements

V. Vicente, V. Pérez-Andreu, N. García-Barberá, 2010, Journal of thrombosis and haemostasis : JTH.

MPI-CDG with transient hypoglycosylation and antithrombin deficiency

J. Corral, V. Vicente, A. Miñano, 2018, Haematologica.

Neutrophil extracellular trap components increase the expression of coagulation factors.

V. Vicente, N. García-Barberá, C. Martínez, 2019, Biomedical reports.

Thrombosis as a conformational disease.

R. Carrell, J. Corral, V. Vicente, 2005, Haematologica.

Genotype–phenotype relationship for six common polymorphisms in genes affecting platelet function from 286 healthy subjects and 160 patients with mucocutaneous bleeding of unknown cause

J. Corral, V. Vicente, O. Panes, 2009, British journal of haematology.

Factor VII –323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk

G. Lip, F. Marín, J. Corral, 2008, Annals of medicine.

Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2017, Scientific Reports.

Heparin affinity of factor VIIa: implications on the physiological inhibition by antithrombin and clearance of recombinant factor VIIa.

S. Kristensen, J. Corral, V. Vicente, 2011, Thrombosis research.

Evaluation of Leukocyte–Depleted Platelet Concentrates Obtained by In–Line Filtration

V. Vicente, R. González-Conejero, F. Ferrer, 2000, Vox Sanguinis.